Gubra A/S
Biotech and CRO focused on peptide drugs for metabolic and fibrotic diseases.
GUBRA | CO
Overview
Corporate Details
- ISIN(s):
- DK0062266474
- LEI:
- 254900T17RRFZONO6W53
- Country:
- Denmark
- Address:
- Hørsholm Kongevej 11 B, 2970 Hørsholm
- Website:
- https://www.gubra.dk/
Description
Gubra A/S is a biotechnology company and preclinical Contract Research Organization (CRO) specializing in peptide-based drug discovery. The company operates a dual business model, providing preclinical research services to pharmaceutical and biotech clients while also developing its own proprietary pipeline of therapeutics. Gubra's primary focus is on metabolic diseases, such as obesity, diabetes, and MASH (metabolic dysfunction-associated steatohepatitis), as well as fibrotic diseases. Its research and development activities also extend into inflammatory conditions, CNS, respiratory, and women's health. The CRO services division supports clients in advancing their drug development programs through expertise in areas like in vivo pharmacology and peptide chemistry.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Gubra A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Gubra A/S
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Gubra A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
